ライフサイエンスコーパス: serum aldosterone

1 activity, -1.27 vs. 0.81 ng/mL/h, p = 0.002; serum aldosterone, -180.9 vs. 3.1 ng/mL/h, p = 0.03), re

2 with lower plasma renin activity (-40%) and serum aldosterone (-48%), less hepatosteatatitis, and a

3 sepsis induction also significantly reduced serum aldosterone and cortisol levels and increased body

4 The associations between serum aldosterone and kidney disease outcomes were asses

5 Even at maximal doses of enalapril, elevated serum aldosterone and plasma AT-II levels were frequentl

6 Elevated serum aldosterone and plasma AT-II levels were observed

7 een high- and low-dose enalapril in terms of serum aldosterone and plasma AT-II suppression, despite

8 udy of Atherosclerosis) with measurements of serum aldosterone and plasma renin activity (PRA).

9 regulates pendrin, as well as the effect of serum aldosterone and potassium on this response, we mea

10 l inhibitor of aldosterone synthase, reduces serum aldosterone, and may have benefit in the treatment

11 kalemic alkalosis, hypercalciuria, increased serum aldosterone, and plasma renin activity, are the tw

12 The association between serum aldosterone concentrations and kidney disease prog

13 Serum aldosterone correlated negatively with creatinine

14 nd LS and e' velocity, respectively, whereas serum aldosterone explained 19% of the indirect effects

15 Individuals with the highest quartile of serum aldosterone had a 45% increased risk of CKD progre

16 correlate with atrial fibrillation (AF) and serum aldosterone in African Americans with heart failur

17 The associations between the serum aldosterone level and blood-pressure outcomes were

18 criteria consisted of unknown postoperative serum aldosterone level and imaging inconsistent with un

19 were observed per quartile increment in the serum aldosterone level.

20 Higher serum aldosterone levels among individuals with CKD are

21 up improvements in plasma renin activity and serum aldosterone levels in the high-dose group, no stat

22 We investigated the relation of baseline serum aldosterone levels to increases in blood pressure

23 Moreover, serum aldosterone levels were increased.

24 The decreases in plasma renin activity and serum aldosterone levels were more evident in pool walki

25 It is unknown whether serum aldosterone levels within the physiologic range in

26 t ventricular systolic dysfunction, elevated serum aldosterone levels, and altered calcium handling i

27 balance, plasma electrolyte concentrations, serum aldosterone levels, and blood pressure.

28 high-K+ diet, despite a 10-fold increase in serum aldosterone levels, implying that mTORC2 regulates

29 rican ancestry was associated with decreased serum aldosterone levels, potentially providing an expla

30 irect effects of systolic blood pressure and serum aldosterone on the relationship between ESI and st

31 Kcne3(-/-) mice exhibited 2.3-fold elevated serum aldosterone (P=0.003) and differentially expressed

32 ine and standing heart rate, blood pressure, serum aldosterone, plasma renin activity, blood volume,

33 The highest serum aldosterone quartile, relative to the lowest, was

34 rican ancestry was inversely correlated with serum aldosterone (r = -0.19, p = 0.037).

35 Serum aldosterone tended to be paradoxically higher with

36 ents were screened for PA using the ratio of serum aldosterone to plasma renin activity.

37 Serum aldosterone, urinary aldosterone, and urinary pota

38 We measured renal function, serum aldosterone, urinary MCP-1 protein excretion, and

39 Serum aldosterone was associated positively with change

40 In adjusted models, each doubling of serum aldosterone was associated with a 11% increased ri

41 The patient's serum aldosterone was markedly elevated with a relativel

42 In these stratified models, serum aldosterone was not a significant predictor of inc

43 Serum aldosterone was significantly higher among patient

44 d ending values of plasma renin activity and serum aldosterone were 6.8 vs. 5.5 ng/mL/h (p = 0.002) a